RSVAX | VMVAX | RSVAX / VMVAX | |
Total Expense Ratio | 1.30 | 0.07 | 1,857% |
Annual Report Gross Expense Ratio | 1.33 | 0.07 | 1,900% |
Fund Existence | 32 years | 14 years | - |
Gain YTD | 2.889 | 7.964 | 36% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 256M | 32.5B | 1% |
Annual Yield % from dividends | 0.37 | 2.17 | 17% |
Returns for 1 year | -6.56 | 5.48 | -120% |
Returns for 3 years | 11.76 | 42.08 | 28% |
Returns for 5 years | 24.20 | 64.91 | 37% |
Returns for 10 years | -17.36 | 102.38 | -17% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IQLT | 45.00 | 0.17 | +0.38% |
iShares MSCI Intl Quality Factor ETF | |||
WBIG | 23.82 | 0.06 | +0.26% |
WBI BullBear Yield 3000 ETF | |||
LTPZ | 53.31 | 0.13 | +0.24% |
PIMCO 15+ Year US TIPS ETF | |||
LIAP | 216.54 | N/A | N/A |
Stone Ridge 2057 Inflation-Protected Longevity Income ETF | |||
ULVM | 90.36 | -0.03 | -0.03% |
VictoryShares US Value Momentum ETF |